Medicare “Average Sales Price” Rule Predicts $800 Mil. In Savings For 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS expects the shift from average wholesale price-based reimbursement to the ASP plus 6% formula to generate savings of $530 mil. to Medicare and $270 mil. to beneficiaries in 2005. The agency expects changes outlined in its proposed rule to bring “transparency and appropriateness” to its payments for Part B drugs.
You may also be interested in...
Bristol To Sell Oncology Distribution Unit Ahead Of Medicare Part B Changes
The company has signed an agreement to sell its Oncology Therapeutics Network to One Equity Partners, Bristol announces. The transaction is expected to close during the first quarter of 2005.
Bristol To Sell Oncology Distribution Unit Ahead Of Medicare Part B Changes
The company has signed an agreement to sell its Oncology Therapeutics Network to One Equity Partners, Bristol announces. The transaction is expected to close during the first quarter of 2005.
CMS Expects No Significant Change In Average Sales Prices Before 2005
The agency’s final 2005 Physician Fee Schedule includes a second round of preliminary ASPs, with data for a larger number of drugs than in the proposed rule. Final average sales prices for the first quarter of 2005 will be published in December.